Table III.

Odds ratios of peripheral arterial disease by inflammatory markers.

Model	Quartile 2	P-value	Quartile 3	P-value	Quartile 4	P-value
Lp-PLA2
1	1.26 (0.53–3.02)	0.81	2.26 (1.97–4.27)	0.37	3.49 (1.32–3.70)	0.02
2	0.89 (0.32–3.65)	0.54	1.98 (1.21–4.14)	0.21	3.24 (1.68–3.94)	0.03
3	0.63 (0.57–2.39)	0.25	1.34 (0.72–3.11)	0.04	1.81 (1.14–3.68)	0.01
Homocysteine
1	2.44 (1.73–3.92)	0.57	3.22 (2.46–4.79)	0.47	3.49 (1.32–3.70)	0.06
2	1.87 (0.82–2.65)	0.44	2.28 (1.61–5.24)	0.37	2.14 (1.07–3.11)	0.04
3	1.03 (1.14–3.76)	0.35	1.17 (2.12–4.55)	0.28	1.15 (0.49–2.69)	0.15
Fibrinogen
1	0.89 (0.87–2.90)	0.15	2.34 (1.77–4.40)	0.23	2.35 (1.52–5.29)	0.03
2	0.65 (0.62–2.73)	0.48	1.97 (0.63–3.87)	0.20	1.93 (1.02–4.01)	0.03
3	0.50 (0.36–1.42)	0.39	1.42 (0.82–3.37)	0.06	1.21 (0.88–5.57)	0.04
Apolipoprotein B
1	0.75 (0.28–2.27)	0. 34	0.79 (0.26–2.15)	0.57	1.26 (0.08–0.81)	0.02
2	0.66 (0.19–2.30)	0.35	0.59 (0.19–2.41)	0.08	2.26 (1.32–5.74)	0.01
3	0.57 (0.22–2.70)	0.63	0.83 (0.06–0.86)	0.24	0.98 (0.51–3.85)	0.01
hsCRP
1	0.79 (0.28–2.27)	0.34	1.26 (0.53–3.00)	0.06	1.54 (0.62–3.80)	0.03
2	0.75 (0.26–2.15)	0.25	0.94 (0.22–3.94)	0.13	1.37 (0.75–2.49)	0.04
3	0.66 (0.19–2.30)	0.12	0.87 (0.21–3.59)	0.09	1.23 (1.12–3.51)	0.20

Data are presented as aOR (95% CI). aOR, adjusted odds ratio; CI, confidence interval; hsCRP, high-sensitivity C-reactive protein; Lp-PLA₂, lipoprotein-associated phospholipase A₂. Model 1, adjusted for age and gender; model 2, further adjusted for smoking status, diabetes, hyper-tension, high cholesterol, use of medication and body mass index (normal, overweight or obese); model 3, further adjusted for all other inflammatory markers. Quartile 1 used as a control group (not shown in table).